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Abstract
We examined whether oral plasma protein supplements affect the innate immune response in a model of acute lung inflammation. Mice
were fed diets supplemented with 8 % spray-dried plasma (SDP) or 2 % plasma Ig concentrate (IC) from day 19 (weaning) until day 34. The
mice were challenged with intranasal lipopolysaccharide (LPS) at day 33 (and killed 24 h later for cytokine and leucocyte analyses) or at
day 34 (and killed 6 h later for cytokine determinations). In bronchoalveolar lavage fluid (BALF), LPS increased the number of leucocytes
by twenty-sevenfold, an effect that was partly prevented by both SDP and IC, and by twentyfold the percentage of activated monocytes,
which was partly prevented by SDP. In the lung tissue, LPS increased the infiltrated leucocytes, and this effect was prevented in part by
SDP. In unchallenged mice, both SDP and IC diets reduced the percentage of resident neutrophils and monocytes (P,0·05). In the blood,
both SDP and IC completely prevented LPS-dependent monocyte activation (CD14þ; P,0·05). LPS dramatically increased the concen-
tration of cytokines (TNF-a, IL-1a, IL-6, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor)
and chemokines (CXCL1, CCL2, CCL3 and CCL4) in BALF. The acute response of cytokine production was reduced by 20–80 % by
both SDP and IC. For chemokines, plasma supplements had no effect on LPS-induced CXCL1 expression but significantly reduced
CCL2, CCL3 and CCL4 production (P,0·05). The results support the view that dietary plasma proteins can be used to attenuate endo-
toxin-associated lung inflammation.
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Acute lung injury is the result of the host response to either
inhaled or endogenous noxious agents and is characterised
by the activation of nasal and bronchoalveolar-associated
lymphoid tissue. Since lungs are constantly exposed to a
large number of micro-organisms and provide a common
entry route for pathogens into the body, lung infection is
one of the most frequent causes of morbidity and death in
humans(1). The inflammation cascade is initiated by the
innate immune system, in which neutrophils have a key role
in the inflammatory response as they contribute to the recruit-
ment, activation and programming of antigen-presenting
cells(2). Furthermore, they generate chemotactic signals that
attract monocytes and dendritic cells(3).
Enteral nutrition has a role in the prevention or amelioration
of inflammatory responses in systemic mucosae. Dietary
lycopene, a carotenoid with a powerful antioxidant capacity,
can decrease eosinophilic infiltrates and reduce Th2 cytokine
responses from lymph nodes, in a mouse model of allergic
airway disease(4). Dietary supplementation with amino acids
such as glycine(5) and tryptophan(6) moderates lung inflam-
mation, while dietary EPA and g-linolenic acid reduce the
risk of mortality in patients with acute respiratory distress syn-
drome(7). Traditional Chinese formulae(8,9) have also been
shown to be effective in the treatment of acute inflammation
in mice challenged with lipopolysaccharide (LPS).
The possible mechanisms for such a therapeutic action are
not well understood. In some cases, the effects are attributed
to the absorbed nutrients acting at extra-intestinal tissues, as
is the case of antioxidant molecules, that once absorbed in
the small intestine, reach the lung, where they prevent or
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reduce oxidative processes(4). In others, the mechanism is
indirect, involving activation of new mediators that eventually
reach the target tissues. This is the case for dietary lecithin,
a source of PUFA-containing phospholipids that mediate
an increase in lipid peroxidation and platelet-activating
factor bioactivity in the lung(10). A third mechanism involves
interaction of luminal contents with mucosal elements. Certain
dietary components interacting with the mucosal lymphoid
tissue (gut-associated lymphoid tissue; GALT) can modulate
the local immune response that, in turn, can modify the
immune response of other mucosal lymphoid tissues due to
the interconnection of the mucosal immune systems(11). This
is the mechanism by which oral bioactive proteins such as
colostrum-derived proteins(12) or milk-derived proteins(13,14)
modify the peripheral immune responses.
In rats challenged with Staphylococcus aureus enterotoxin
B, dietary supplementation with spray-dried plasma proteins
(SDP) reduced the mucosal immune response in both the
organised and diffused GALT, protecting the gut mucosal
lymphoid tissue from excessive activation(15,16,17). SDP can
also modulate the mucosal immune response in extra-intesti-
nal tissues; for example, in an epidemiological study of
Canadian swine farms, feeding plasma proteins was associated
with reduced mortality due to porcine reproductive and res-
piratory syndrome(18). Other peripheral effects of dietary
SDP involve changes in the activation of the pituitary–adrenal
axis following an LPS challenge(19) and reduced mRNA
expression of TNF-a and IL-1b in the adrenal gland, spleen,
hypothalamus, pituitary gland and liver(20).
Since this class of supplements also improves the survival
and performance of turkeys during a respiratory challenge
stimulated by Pasteurella multocida (21), we investigated the
therapeutic potential of plasma supplements in a mouse
model of acute lung inflammation, based on the intranasal
administration of LPS. Specifically, we studied the innate
immune system because this mediates the defence against
pathogens and regulates tissue health and integrity(2).
Material and methods
Animals and diets
Male C57BL/6 mice were supplied by Harlan Ibe´rica
(Barcelona, Spain) and kept under stable temperature and
humidity conditions, with a 12 h light–12 h dark cycle and
free access to food and water. All protocols used in the present
study were approved by the Ethics Committees for Animal
Experimentation of the University of Barcelona (Barcelona,
Spain) and the Catalan government. The animals were weaned
at day 19 after birth, distributed at random in groups of seven
to eight mice (two to three animals per cage) and fed the
experimental diets for 2 weeks. This time period was adequate
for plasma supplements to demonstrate their effect on
immune response. The mice were monitored for food intake
and body weight throughout the experimental period. Dietary
treatments included (1) control: mice fed the control diet;
(2) SDP: mice fed a diet with 8 % SDP; (3) Ig concentrate
(IC): mice fed a diet with 2 % IC (provided the same amount
of Ig as the SDP diet); (4) LPS: mice fed a control diet and
challenged with LPS; (5) LPS-SDP: mice fed the diet with 8 %
SDP and given LPS; (6) LPS-IC: mice fed the diet with 2 % IC
and treated with LPS.
SDP is a feed ingredient obtained by centrifuging blood
from healthy pigs, and IC is obtained by removing most of
the albumin from plasma, resulting in a fraction containing
approximately 40 % Ig(22). Both ingredients were spray-dried
to obtain a stable powder. Maintenance of the native structure
of the protein was confirmed by immunoelectrophoresis
and Western blotting(23). The diets were balanced for energy
and total N, and lysine and methionine were formulated to
meet the National Research Council requirements(24) for lab-
oratory animals (Table 1). The N content of the control diet
was adjusted with milk protein. All diets were prepared by
Harlan Ibe´rica.
Lipopolysaccharide challenge
LPS from Escherichia coli (O128:B12; Sigma-Aldrich, St Louis,
MO, USA) was dissolved in PBS (625mg/ml). The mice
(16–18 g body weight) were anaesthetised with isofluorane
on day 33 (for 24 h sampling) or on day 34 of life (for 6 h
sampling), and were administered 10ml of the LPS solution
(or PBS) in each nostril. To collect bronchoalveolar lavage
fluid (BALF), lung and blood for analysis of the lymphocytes
(24 h after the LPS treatment) or cytokines (6 and 24 h after
LPS), the mice were anaesthetised by intraperitoneal adminis-
tration of ketamine (80 mg/kg) and xylazine (6 mg/kg). Blood
was withdrawn by cardiac puncture. At the end of the exper-
iment, the mice were killed by cervical dislocation. The
samples used for protein and RNA determinations were
immediately frozen with liquid N2 and stored at 2808C.
Bronchoalveolar lymphocytes
Bronchoalveolar lavage was performed by the intra-tracheal
instillation of 1 ml PBS(25). The BALF was recovered (0·8–
0·9 ml) and centrifuged at 950 g for 10 min, and the pelleted
BALF cells were re-suspended in PBS–FBS. The cells were
Table 1. Composition of experimental diets
Ingredient Control SDP (g/kg) IC
Spray-dried animal plasma (SDP*) – 80 –
Ig fraction concentrate (IC†) – – 20
Maize starch 199 308·8 223·6
Skimmed milk 531 340·5 486·7
Sugar 94·5 94·5 94·5
Soyabean oil 70 70 69·6
Cellulose 50 50 50
AIN-93 GM‡ 35 35 35
AIN-93 VX‡ 15 15 15
DL-Methionine 2·5 3·2 2·6
Choline bitartrate 3 3 3
Total 1000 1000 1000
SDP, spray-dried plasma, IC, Ig concentrate.
* SDP from porcine blood (AP-820; APC-Europe S.A., Granollers, Spain).
† APC-Europe S.A.
‡ Provided by Harlan Ibe´rica (Barcelona, Spain).
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counted, and viability was determined with a solution of acri-
dine orange and ethidium bromide. In all cases, cell viability
was higher than 95 %. The supernatant was frozen at 2808C
for further analysis.
Lung lymphocytes
Once BALF was obtained, the samples of the lung tissue were
excised for protein, cell isolation and mRNA determinations.
The lung lymphocytes were isolated according to Woolard
et al.(25). Briefly, the lung tissue was washed and later
was finely minced and incubated in Roswell Park Memorial
Institute (RPMI) 1640 (Invitrogen, Carlsbad, CA, USA) with
5 % FBS, 100 000 U/l penicillin, 100 mg/l streptomycin,
10 mM-HEPES, 2 nM-L-glutamine and 150 U/ml collagenase
(Invitrogen). After incubation for 90 min at 378C in an auto-
matic shaker, the remaining intact tissue was disrupted by
passage through a 21-gauge needle. The suspension was
centrifuged at 600 g for 7 min at 48C. The supernatant was
discarded, and the pellet was suspended in 40 % Percoll (GE
Healthcare Bio-Sciences, Little Chalfont, Bucks, UK) layered
onto 80 % Percoll and centrifuged at 600g for 20 min at
158C. The cells at the interface were collected, washed in
RPMI-1640 with FCS, HEPES and penicillin/streptomycin,
and suspended in PBS–FBS. The cells were counted, and
viability was determined as described earlier. In all cases,
cell viability was higher than 75 %.
Blood lymphocytes
After cervical dislocation, the blood was drawn by cardiac
puncture with a heparinised syringe and mixed with 7 ml
of erythrocyte lysing buffer (0·17 M-NH4Cl, 0·01 M-KHCO3,
0·1 mM-EDTA, adjusted at pH 7·3). This solution remained at
room temperature for 5 min and was then centrifuged at
300 g for 5 min at 258C. The cells obtained from the pellet
were washed with PBS–FBS and centrifuged at 300g for
5 min at 48C. The supernatant was discarded, and the cells
were suspended in the same solution.
Cell staining
The cells (3 £ 104 for the BALF samples and 1·5 £ 105 for
the lung and blood samples) were incubated with primary
mouse monoclonal antibodies for 30 min at 48C. The primary
antibodies used were anti-CD45 APC-A750 (eBioscience,
Inc., San Diego, CA, USA) for leucocytes; lymphocytes and
non-lymphocytic leucocytes were separated by forward/side
scatter; anti-CD68 A700 (eBioscience, Inc.) for monocytes,
anti-Ly6G FITC (BD Pharmingen, Franklin Lakes, NJ, USA)
for neutrophils, anti-CD14 PE (eBioscience, Inc.) for activated
neutrophils/monocytes; and isotype control. The samples
were subsequently washed in PBS–FBS and centrifuged at
600 g for 6 min at 48C. Finally, the washed cells were fixed
with 400ml of 4 % w/v paraformaldehyde and stored at 48C
until analysis. The samples were analysed in a BD FACSAriae
Flow Cytometer at the Cytometry Unit of the Scientific and
Technical Support Services of the University of Barcelona.
Lung homogenate
The samples were homogenised in a lysis buffer containing
0·1 mM-EDTA, 0·1 mM-ethylene glycol tetraacetic acid, 1 %
Triton and 2 % protease inhibitor cocktail (Sigma-Aldrich).
The homogenate was centrifuged at 48C at 14 000g for
10 min. The IL-10 was determined in the supernatant (see
later). The amount of protein in the lung homogenate and
supernatant was assayed by the Bio-Rad protein assay (Bio-
Rad, Hercules, CA, USA).
Cytokine and chemokine assays
The cytokines determined were IL-1a, IL-1b, TNF-a, IL-6,
granulocyte-macrophage colony-stimulating factor (GM-CSF)
and granulocyte CSF (G-CSF). The chemokines CCL2, CCL3,
CCL4 and CXCL1 were studied by means of the Bio-Plex
Mouse Cytokine Panel (Bio-Rad) in samples of BALF super-
natants from animals killed 6 and 24 h after the LPS challenge.
The cytokine IL-10 was studied in samples of the lung hom-
ogenate with the Bio-Plex Mouse Cytokine Assay (Bio-Rad).
The detection limits were 0·8 pg/ml for IL-1a; 5·8 pg/ml for
IL-1b; 12 pg/ml for TNF-a; 1·4 pg/ml for IL-6; 8·1 pg/ml for
GM-CSF; 2·3 pg/ml for G-CSF; 6·4 pg/ml for CCL2; 13 pg/ml
for CCL3; 2·7 pg/ml for CCL4; and 1·6 pg/ml for CXCL1.
The detection limit for IL-10 was 2·1 pg/ml.
RNA extraction and RT
Frozen samples of lung tissue taken from animals 6 h after the
LPS challenge were disrupted mechanically, and total RNA
was extracted with TRIzol (Invitrogen) following the manufac-
turer’s instructions. Extracted RNA was treated with RQ1
RNase-free DNAase (Promega, Inc., Madison, WI, USA) and
reverse transcribed with Superscripte III RT (Invitrogen)
using an oligo-(dT)20 primer, according to the supplier’s pro-
tocol (Invitrogen).
Real-time PCR
Complementary DNA served as a template in a 20ml reaction
volume containing 0·2mmol/l of each primer: inducible NO
synthase (iNOS), forward: 50-GGC AAC ATC AGG TCG GCC
ATC AC-30, reverse: 50-CGT ACC GGA TGA GCT GTG AAT
T-30 (122 bp); glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), forward: 50-GGC ATT GCT CTC AAT GAC AA-30,
reverse: 50-CCC TGT TGC TGT AGC CGT AT-30 (73 bp) and
2x SyBrw GreenER SuperMix (Invitrogen). Real-time PCR
was performed in an ABI Prism 7000 Sequence Detection
System (Applied Biosystems, Carlsbad, CA, USA). The PCR
conditions were as described previously(26).
Statistical analysis
All results are expressed as means with their standard errors.
The effects of LPS and diets (and their interaction) on leuco-
cyte populations and on iNOS expression were analysed
by two-way factorial ANOVA, followed by the Bonferroni
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post hoc test. Cytokine and chemokine concentrations were
analysed by three-way ANOVA (LPS challenge, time, diet
and their interactions), followed by the Bonferroni post hoc
test, using SPSS 14.0 software (SPSS, Inc., Chicago, IL, USA).
Differences were considered significant at P,0·05.
Results
Leucocyte counts and cell populations
Intra-nasal administration of LPS induced an immune response
in BALF, lung tissue and blood that was consistent and repro-
ducible, and with low variability. In the lung airways, there
was massive leucocyte recruitment (thirty-fivefold increase
in BALF; P,0·001; Fig. 1(A)), which was reduced by 25 %
by SDP (P,0·05) and by 37 % by IC (P,0·05). LPS adminis-
tration increased the recruitment of the lymphocytes and
non-lymphocytic leucocytes into the lung airways (P,0·05),
and both were significantly reduced by SDP and IC (Fig. 1(A)).
In control mice, the majority of BALF non-lymphocytic
leucocytes was monocytes (94·3 %), while only 2·6 % were
neutrophils (Table 2). This profile was reversed by LPS since
the neutrophil population became several-fold higher than
the monocyte population, and this cellular shift was not
affected by dietary treatment. LPS also increased 3·5-fold the
percentage of activated neutrophils and twentyfold the popu-
lation of activated monocytes. Both SDP and IC supplements
reduced the percentage of activated neutrophils, but only
SDP prevented in part monocyte activation in the challenged
mice (Table 2).
In the lung tissue, LPS increased leucocyte recruitment
by 30 % (Fig. 1(B)), and this effect was completely prevented
by SDP supplementation. However, the effects of LPS on
the relative distribution of leucocyte subsets (Table 2) were
not modified by the plasma supplements. Interestingly, both
supplements reduced the percentage of monocytes and
neutrophils in the unchallenged groups. As to the degree of
activation of these cells, LPS increased the percentage of
activated neutrophils almost threefold and that of activated
monocytes over thirtyfold, whereas dietary supplements did
not modify this response.
In the blood, LPS induced a leucocyte distribution profile
similar to that observed in the lung tissue, i.e. an increase
in the percentage of activated neutrophils and monocytes
(tenfold and threefold, respectively), which were partially
inhibited by both plasma supplements (Table 2).
Chemokine and cytokine
Chemokine and cytokine expression is presented in Figs. 2
and 3, respectively. Although most of the variables showed
maximal responses at 6 h, there were still significant differ-
ences 24 h after the LPS challenge. In general, the response
to LPS was a several-fold increase in the expression of cyto-
kines and chemokines, both 6 and 24 h after the challenge.
The effect of LPS on chemokines at 6 h was significant,
especially on the expression of CCL3 (a more than 1000-fold
increase; Fig. 2). At 24 h, the response was still significant.
Dietary treatment reduced chemokine production at both 6 h
(CCL2, CCL3 and CCL4) and at 24 h (CCL3 and CCL4, Fig. 2).
For cytokines, the highest response was obtained for IL-6,
TNF-a and G-CSF (more than 1000-fold increase; Fig. 3),
and the response at 6 h, with the exception of IL-1a, was
higher than at 24 h. Both dietary treatments were effective in
reducing cytokine concentration, including an 80 % reduction
in TNF-a and a 30 % reduction in IL-1a expression. In spite of
increased variability in cytokine concentrations 24 h after LPS
challenge, both dietary treatments reduced the levels of IL-
1a and TNF-a (Fig. 3). The expression of IL-10 in the lung
tissue is shown in Fig. 4. LPS had no effect on its concentration
in the tissue, but both SDP and IC supplements stimulated its
expression in the challenged mice.
Inducible NO synthase expression
In the lung tissue, LPS increased iNOS expression by 13 % (LPS
group, 1·13 (SEM 0·03); control group, 1·00 (SEM 0·02);
P,0·05), and this effect was removed by both the SDP and
IC supplements (LPS-SDP, 0·99 (SEM 0·04) and LPS-IC, 1·02
(SEM 0·02); both P,0·05).
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Fig. 1. Cell count in (A) bronchoalveolar lavage fluid and (B) lung tissue in control ( ), spray-dried plasma (SDP, ), Ig concentrate (IC, ), lipopolysaccharide
(LPS, ), LPS-SDP ( ) and LPS-IC ( ) mice. Values are means, with their standard errors represented by vertical bars, n 7–8. (A) The LPS effect, the diet effect
and the interaction between diet and LPS were significant in the three cell types (P,0·001, P,0·05 and P,0·05, respectively). (B) The LPS effect was significant
in leucocytes and granulocytes (P¼0·018); the diet effect was significant in the three cell types (P,0·05); the interaction between diet and LPS administration
was significant only in lymphocytes (P,0·05). a,b,c Mean values with unlike letters were significantly different (P , 0·05)
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Discussion
Dietary spray-dried plasma proteins are widely used in farm
animal nutrition because they maintain normal intestinal
barrier function and growth performance(27). They also
have anti-inflammatory effects as they attenuate the mucosal
inflammatory response in the small intestine of rats exposed
to a staphylococcal enterotoxin(28,29); in humans, bovine
immunoglobulin concentrates reduce the clinical effects of
cryptosporidiosis with AIDS(30).
In addition to its effects on gut homeostasis, which involve
modulation of GALT(28), animal plasma supplements can
also affect lymphoid tissue populations and the expression
of cytokines in peripheral tissues, such as the spleen and the
liver(20), and in the lungs(21). These observations have led to
the hypothesis that dietary plasma supplements may also be
effective in modulating the response of the immune cells in
the non-intestinal mucosal tissues such as the nasopharyngeal
mucosa (nasal and bronchoalveolar-associated lymphoid
tissue). This hypothesis is sustained by the existence of the
common mucosal immune system that connects the inductive
sites (here the GALT) with the effector sites (nasal and bronch-
oalveolar-associated lymphoid tissue) for the generation of
T lymphocyte responses(11).
The study was done during the post-weaning period,
because at this stage the mucosal immune system is still imma-
ture and therefore more susceptible to infection(31); further-
more, we had demonstrated in rats that plasma supplements
are already effective in this early period(17). In the mouse
model of acute lung inflammation induced by LPS, the pul-
monary response is characterised by lymphocyte migration
and the massive release of pro-inflammatory cytokines and
chemokines, which recruit monocytes and neutrophils into
the lung airway and into the lung tissue(9,32). We were primar-
ily interested in the effects of SDP and IC on the innate
immune response because of its triple role: first, mediating
the defence against pathogens; secondly, detecting tissue
damage, and finally, regulating tissue health and integrity(2).
The main finding of the present study is that dietary sup-
plementation with SDP or IC reduces the innate immune
response to LPS inhalation. The reduction in leucocyte
counts in BALF and the lung tissue, the lower concentration
Table 2. Populations of neutrophils and monocytes in bronchoalveolar lavage fluid (BALF), lung and blood after 24 h administration in control, spray-
dried plasma (SDP), Ig concentrate (IC), lipopolysaccharide (LPS), LPS-SDP and LPS-IC mice
(Mean values with their standard errors, n 7–8)
LPS
challenge
Control diet SDP diet IC diet LPS effect Diet effect LPS £ diet
interaction
Means SEM Means SEM Means SEM P P P
BALF (%)
Non-lymphocytic leucocytes
Neutrophils No 2·6 0·2 2·0 0·2 3·2 0·5
,0·001 NS NSYes 69·7 7·1 71·8 3·9 81·4 2·7
Monocytes No 94·3 0·7 94·7 0·8 93·7 0·9
,0·001 NS NSYes 9·3 2·4 9·1 0·6 8·7 1·4
Neutrophils
Activated No 24·0a 5·5 18·5b 4·4 17·4b 1·8
,0·001 0·048 NSNeutrophils Yes 84·2a 1·1 78·1b 3·7 75·7b 3·7
Monocytes
Activated No 0·8 0·2 0·6 0·2 0·6 0·1
,0·001 0·042 0·049Monocytes Yes 16·3a 2·0 9·7b 1·3 13·7a,b 3·3
Lung (%)
Non-lymphocytic leucocytes
Neutrophils No 18·3a 0·5 14·8b 0·9 15·1b 1·3
,0·001 NS 0·038Yes 29·4 1·5 32·5 3·2 29·7 4·1
Monocytes No 19·1a 2·4 12·2b 1·3 13·4b 1·7
,0·001 NS 0·017Yes 32·1 3·9 28·7 3·3 32·6 4·1
Neutrophils
Activated No 2·1 0·6 1·0 0·2 0·8 0·2
,0·001 NS NSNeutrophils Yes 5·4 1·1 7·2 2·0 7·2 2·0
Monocytes
Activated No 0·5 0·2 0·3 0·1 1·1 0·4
,0·001 NS NSMonocytes Yes 17·4 3·7 16·6 4·8 17·7 3·8
Blood (%)
Non-lymphocytic leucocytes
Neutrophils No 15·7a 0·7 8·3b 0·7 8·9b 0·6
0·034 ,0·001 NSYes 16·2a 1·9 9·3b 1·3 13·6b 1·3
Monocytes No 19·7 1·1 16·6 2·1 16·6 1·9
,0·001 NS NSYes 51·6 6·3 56·5 4·2 48·1 4·7
Neutrophils
Activated No 0·32a 0·03 0·57b 0·09 0·67b 0·09
,0·001 NS 0·019Neutrophils Yes 3·5a 0·7 1·5b 0·4 1·8b 0·5
Monocytes
Activated No 1·0a 0·2 1·0a 0·1 1·7b 0·2
,0·001 NS 0·001Monocytes Yes 3·2a 0·5 1·9b 0·4 1·4b 0·2
a,b Mean values within a row with unlike superscript letters were significantly different (P,0·05).
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of pro-inflammatory cytokines and chemokines in BALF, and
the lower iNOS expression in the lung tissue, all suggest a
dietary-dependent reduction in the chemical mediators
responsible for acute lung injury. These results agree with
previous observations in rats indicating that dietary plasma
proteins protect the intestine from immune overstimulation
caused by the intraperitoneal administration of S. aureus
enterotoxin B(17). The mechanism of action involves a
reduction in the pro-inflammatory to anti-inflammatory cyto-
kine ratios in both Peyer’s patches and the mucosa(26).
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spray-dried plasma (SDP, ), Ig concentrate (IC, ), lipopolysaccharide (LPS, ), LPS-SDP ( ) and LPS-IC ( ) mice 6 and 24 h after the LPS challenge. Values
are means, with their standard errors represented by vertical bars, n 5–6. The LPS effect was significant in the six cytokines studied (P,0·001); the diet effect
was significant for IL-1a, IL-1b, IL-6 and G-CSF (P#0·039) and for TNF-a (P,0·001); the time effect was significant except for IL-1b (P#0·010); the interaction
between diet and LPS was significant for IL-1a, IL-1b, IL-6 and G-CSF (P#0·05) and for TNF-a (P,0·001); the interaction between LPS and time was significant
for all the cytokines except for IL-1b (P#0·010). a– f Mean values with unlike letters were significantly different (P,0·05).
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In mice that were not exposed to LPS, the number of
leucocytes recruited into the airway was low, with a clear
predominance of monocytes, and a very low amount of
neutrophils. The LPS challenge increased cell recruitment to
the airway space; specifically, the percentage of neutrophils
increased by 70 %. These findings are consistent with the
results reported by Reutershan et al.(32) who used a similar
model. The primary function of neutrophils in the innate
immune response is to contain and kill invading microbial
pathogens(3), and their concentration in BALF is a maximal
24 h after LPS administration(32). In BALF and the lung tissue,
LPS increased the proportion of activated neutrophils (three-
and twofold, respectively) and of activated monocytes
(twenty- and thirty-fourfold, respectively), as a consequence
of the release of large amounts of chemokines, in agreement
with the previous observations(9). The effects of LPS on leuco-
cyte counts in BALF were attenuated by SDP and IC, indicating
lower cell infiltration, consistent with reduced eosinophil infil-
tration and lower degree of degranulation observed in the
intestine of rats challenged with S. aureus enterotoxin B(28).
Both the plasma supplements reduced the percentage of
activated neutrophils and monocytes in the lung airway;
therefore, lower cell migration and smaller activation of
inflammatory cells to the pulmonary tissue may reduce the
potential damage to the respiratory epithelium and vascular
endothelium associated with the inflammatory response.
The main effects of dietary supplementation with plasma
proteins were observed in the lung airway, but there were
also marked effects in the lung tissue and in peripheral
blood. It is noteworthy that there is a reduction in the resident
monocytes and neutrophils in the lung tissue, which implies a
reduction in the normal pro-inflammatory state associated
with the mucosal system(33). At a systemic level, both diets
decreased the percentage of activated monocytes and acti-
vated neutrophils induced by LPS, consistent with the
reduction in the percentage of activated monocytes and acti-
vated neutrophils in the lung airway observed in the
plasma-supplemented mice. The finding that diet reduces
the activation of neutrophils and monocytes is important,
because these populations are involved in the acute lung
injury induced by LPS(34).
Inhaled LPS increased cytokine and chemokine concen-
tration as well as iNOS expression in the lung tissue and in
BALF, in agreement with the previous observations(9). More-
over, pro-inflammatory cytokines can alter the structure of
the respiratory and vascular epithelia, which compromise
the gas exchange. For example, excess TNF-a enhances the
paracellular permeability of microvascular endothelial cells
leading to tissue dysfunction and shock(35). The present results
show that LPS increased TNF-a concentration in BALF at 6 h,
reaching a concentration 1700-fold higher than in the controls,
which dropped to only sixtyfold 24 h after the challenge, con-
sistent with the previous reports(36). The concentration in
BALF of the other pro-inflammatory cytokines studied was
also dramatically increased at 6 h, confirming the observations
of Yeh et al.(9) and partly prevented by both SDP and IC. The
effects of SDP and IC on GM-CSF expression may be of special
significance, because it plays an important role in the patho-
genesis of acute and chronic lung disease(37).
Since chemokines attract leucocytes into tissues, they are
good indicators of the inflammatory state. CCL2 recruits mono-
cytes, lymphocytes and basophils, and activates mast cells and
basophils(38). The pattern of the response of chemokines in
BALF was similar to that of cytokines, i.e. most of them
(CXCL1 and CCL3) showed an acute response that was greater
at 6 h than at 24 h, whereas CCL2 was much more evident at
24 h after the challenge. Both SDP and IC attenuated the
LPS-induced increase in chemokine concentration, and this
effect is relevant due to the role of chemokines as inducers
of cell migration into the bronchoalveolar space during
inflammation.
The mechanism of action of dietary functional proteins is
not well understood. Spray-dried plasma contains biologically
active peptides and functional proteins including Ig (IgA, IgG
and IgM), albumin and growth factors(23). These proteins
show special efficacy when the animals are exposed to
environmental or immunological challenges. The IC sup-
plement lacks most of the albumin fraction, and therefore
it contains higher amounts of g-globulins. Although it has
been suggested that IgG is responsible for the SDP effects(39),
the contribution of other active plasma components to the
functional effects of plasma supplements should also be con-
sidered. Plasma contains over 250 active peptides(40) that
retain most of their biological activity after spray drying(23).
The main effects of SDP and IC involve regulation of mucosal
GALT, which may be the result of reduced mucosal binding of
luminal antigens mediated by plasma glycoproteins(39). GALT
regulation can also be ascribed to changes in the profile of the
gut microflora(41) or to the biological activity of other plasma
components either interacting with luminal extensions of den-
dritic cells or crossing the epithelium across M cells or through
tight-junction complexes. Although the interaction of SDP and
IC with the intestinal mucosa is not yet clarified, it is well
demonstrated that plasma supplements modulate the
expression of pro-inflammatory cytokines in the GALT of
pigs(42) and rats(26). Our studies in the rat model of mild intes-
tinal inflammation(29) indicate that the mechanism by which
plasma supplements reduce GALT activation may also involve
profile modulation of cytokines(26).
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Fig. 4. Concentration of IL-10 in lung tissue from control ( ), spray-dried
plasma (SDP, ), Ig concentrate (IC, ), lipopolysaccharide (LPS, ),
LPS-SDP ( ) and LPS-IC ( ) mice 6 h after the LPS challenge. Values are
means, with their standard errors represented by vertical bars, n 5–6.
a,b,c Mean values with unlike letters were significantly different (P,0·05).
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Cuzzocrea et al.(43) have shown that IL-10 has also an
important role during acute lung inflammation, inhibiting
the release of pro-inflammatory mediators such as IL-6(44)
and iNOS(45). In contrast to the mild response induced by
S. aureus enterotoxin B in the intestine, the effects of LPS in
the lung are characterised by increased leucocyte recruitment
and strongly enhanced cytokine and chemokine production.
However, even in this acute inflammatory condition, both
SDP and IC inhibited the immune response, indicating that
dietary modulation of intestinal lymphocyte proliferation(17)
and cytokine expression(26) can reduce inflammatory res-
ponses in distant regions, albeit interconnected by the
common mucosal immune system. The analysis of IL-10 in
the lung tissue showed that both SDP and IC supplements
can significantly increase its expression, supporting the view
that the peripheral anti-inflammatory effects of plasma sup-
plements also involve modulation of the cytokine ratios.
In conclusion, dietary SDP or IC interacts with the immune
cells of GALT and reduces the pulmonary response to an LPS
challenge, consistent with the hypothesis that there is exten-
sive communication between the mucosal tissues through
the common mucosal immune system. The present results
support the view that oral intervention with plasma protein
supplements is a new strategy for preventing, managing and
attenuation of lung inflammation.
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